Newsroom | 1933 results

DUBLIN--(BUSINESS WIRE)--The "United States Hempcrete Market Report by Application, End Use, States and Company Analysis, 2025-2033" report has been added to ResearchAndMarkets.com's offering. The United States Hempcrete Market is estimated to grow substantially from US$ 7.83 Billion in 2025 to US$ 10.60 Billion in 2033. The growth is fueled by increasing demand for environmentally friendly building materials and sustainable construction methods. With an expected Compound Annual Growth Rate (CA...

SAN FRANCISCO--(BUSINESS WIRE)--Nabis acquires Humble Cannabis Solutions assets, expanding California distribution, adding $13M in assets, and strengthening wholesale infrastructure....

BRIDGEPORT, W. Va.--(BUSINESS WIRE)--Harvest Care Medical, announced the opening of two new medical cannabis dispensaries in Morgantown, West Virginia and Parkersburg, West Virginia, both operating under its consumer-facing brand, Country Grown Cannabis. With these openings, Harvest Care Medical now operates 10 dispensaries in West Virginia, all branded as Country Grown Cannabis. The new Country Grown Cannabis locations expand Harvest Care Medical’s footprint in West Virginia and further the co...

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share1, today announced the expansion of its innovation investment in Phylos Bioscience Inc. (“Phylos”), securing Organigram’s position as a leader in seed-based cannabis genetics. Through an amended loan and product agreement, Organigram gains priority access to Phylos’ autoflower genetics pipeline, including preferential economic terms and long-ter...

WEST BERLIN, N.J.--(BUSINESS WIRE)--United Food and Commercial Workers (UFCW) Local 360 today announced that workers at the NJ Leaf dispensary in North Brunswick have voted to unionize, making it the second NJ Leaf location to join the union. NJ Leaf owner Ritesh Shah supports the decision, underscoring NJ Leaf’s commitment to building a safe, inclusive, and rewarding environment for both employees and customers. The newly organized North Brunswick employees join colleagues at NJ Leaf’s Freehol...

AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced that the Board of Directors has decided to commence a cash tender offer as part of its plan to “go private” in lieu of the previously announced reverse stock split at a ratio of not less than 1-for-2,500 and not greater than 1-for-7,500. Volunta...

CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that, following a go-shop process, it has entered into an agreement to sell all of the ownership interests of its subsidiary engaged in the business of cultivating, producing, manufacturing, distributing and selling cannabis in the C...

TORONTO & SEATTLE--(BUSINESS WIRE)--POSaBIT (CSE: PBIT, OTC: POSAF), a leading provider of point-of-sale and payments infrastructure for the cannabis industry, today expressed strong support for the federal government’s decision to reschedule cannabis from a Schedule I to a Schedule III substance under the Controlled Substances Act. The change marks one of the most significant federal cannabis policy shifts in decades and represents a major inflection point for licensed cannabis operators natio...

TAMPA, Fla.--(BUSINESS WIRE)--Mint Cannabis Expands Into Florida with 18 Community-Focused Dispensaries...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump’s action to reschedule cannabis from a Schedule I to Schedule III substance under the Controlled Substances Act. “Today marks the most consequential moment in the history of U.S. cannabis. The decision to move cannabis from Schedule I to Schedule III will be a cultural turning point, ackn...